Valuation China Shineway Pharmaceutical Group Limited OTC Markets
Stocks
CSWY.Y
US16947J1007
Pharmaceuticals
|
Market Closed -
OTC Markets
15:15:08 2025-05-13 EDT
|
5-day change | 1st Jan Change | ||
| 19.25 USD | -1.03% |
|
-.--% | - |
| 05-07 | China Shineway Pharmaceutical's Turnover Slides 18% in Q1 | MT |
| 05-07 | China Shineway Pharmaceutical posts Q1 turnover of RMB624 mln | RE |
Company Valuation: China Shineway Pharmaceutical Group Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,240 | 5,072 | 4,985 | 6,850 | 5,838 | 5,221 | - | - |
| Change | - | 19.61% | -1.71% | 37.41% | -14.78% | -10.57% | - | - |
| Enterprise Value (EV) | 49.32 | 25.13 | 4,985 | 6,850 | 5,838 | 5,221 | 5,221 | 5,221 |
| Change | - | -49.04% | 19,734.74% | 37.41% | -14.78% | -10.57% | 0% | 0% |
| P/E | 7.59x | 6.99x | 5.16x | 8.17x | 6.13x | 5.46x | 4.87x | 4.41x |
| PBR | 0.72x | 0.79x | 0.71x | - | 0.72x | 0.6x | - | - |
| PEG | - | 0.2x | 0.2x | -0.6x | 0.5x | 13.76x | 0.4x | 0.4x |
| Capitalization / Revenue | 1.32x | 1.28x | 1.1x | 1.81x | 1.86x | 1.72x | 1.6x | 1.49x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.72x | 1.6x | 1.49x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 5.28x | 4.68x | 4.24x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 5.28x | 4.68x | 4.24x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.39 | 0.32 | 0.42 | 0.54 | - | - | - | - |
| Rate of return | 6.95% | 4.77% | 6.36% | 5.95% | - | - | - | - |
| EPS 2 | 0.74 | 0.96 | 1.28 | 1.11 | 1.26 | 1.265 | 1.419 | 1.567 |
| Distribution rate | 52.7% | 33.3% | 32.8% | 48.6% | - | - | - | - |
| Net sales 1 | 3,224 | 3,951 | 4,517 | 3,778 | 3,135 | 3,034 | 3,263 | 3,513 |
| EBITDA 1 | 826 | 1,022 | 1,316 | 1,306 | 1,047 | 989.5 | 1,115 | 1,231 |
| EBIT 1 | 643.6 | 835.8 | 1,139 | 1,025 | 896 | 989.5 | 1,115 | 1,231 |
| Net income 1 | 556.7 | 722.8 | 969.5 | 840.1 | 949.9 | 955.9 | 1,072 | 1,184 |
| Net Debt | -4,191 | -5,046 | - | - | - | - | - | - |
| Reference price 2 | 5.613 | 6.714 | 6.599 | 9.068 | 7.728 | 6.911 | 6.911 | 6.911 |
| Nbr of stocks (in thousands) | 755,400 | 755,400 | 755,400 | 755,400 | 755,400 | 755,400 | - | - |
| Announcement Date | 3/29/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.1x | 6.58x | 22.81x | 0.9% | 47.71B | |
| 18.6x | 2.22x | 10.04x | 1.39% | 40.3B | |
| 27.88x | 3.39x | 17.57x | 0.91% | 12.09B | |
| 26.85x | 3.84x | 15.92x | 0.6% | 11.68B | |
| 18.73x | 3.33x | 11.58x | 3.85% | 9.19B | |
| 9.03x | 2.08x | 5.42x | 4.46% | 7.57B | |
| 15.95x | 2.08x | 6.76x | 3.2% | 7.24B | |
| 28.19x | 3.68x | 17.11x | 0.16% | 6.84B | |
| Average | 22.54x | 3.40x | 13.40x | 1.93% | 17.83B | |
| Weighted average by Cap. | 25.41x | 4.04x | 15.46x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2877 Stock
- CSWY.Y Stock
- Valuation China Shineway Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
